Latest filing published 01 Sept 2026 for Alkermes plc., €106k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Craig C. Hopkinson across 2 companies, led by Alkermes plc. and Albireo Pharma, Inc. Over a trading history stretching from 7 June 2021 to 1 September 2026, the count stands at 54 filings.
On the market, this insider has only sold: 16 sales, €4.8M in total. No amount is published for 2 filings, which the totals therefore leave out. Besides market trades, the filings include 7 share grants and 31 option exercises. 2026 to date brings no purchases and 8 sales.
The record was last updated on 1 September 2026 with an option exercise (€106k) in Alkermes plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations